|
WTX (form Factor)
WTX can refer to: * WTX (form factor) * Another name for the gene FAM123B FAM123B is a human gene, also referred to as WTX. It has been associated with Wilms tumor Wilms' tumor or Wilms tumor, also known as nephroblastoma, is a cancer of the kidneys that typically occurs in children, rarely in adults.; and occur ... * WTX101, a bis-choline tetrathiomolybdate de-coppering therapy {{Disambig pl:WTX ru:WTX ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
WTX (form Factor)
WTX can refer to: * WTX (form factor) * Another name for the gene FAM123B FAM123B is a human gene, also referred to as WTX. It has been associated with Wilms tumor Wilms' tumor or Wilms tumor, also known as nephroblastoma, is a cancer of the kidneys that typically occurs in children, rarely in adults.; and occur ... * WTX101, a bis-choline tetrathiomolybdate de-coppering therapy {{Disambig pl:WTX ru:WTX ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
FAM123B
FAM123B is a human gene, also referred to as WTX. It has been associated with Wilms tumor Wilms' tumor or Wilms tumor, also known as nephroblastoma, is a cancer of the kidneys that typically occurs in children, rarely in adults.; and occurs most commonly as a renal tumor in child patients. It is named after Max Wilms, the German .... References {{gene-X-stub ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
Bis-choline Tetrathiomolybdate
Tiomolibdic acid (trade name Decuprate) is a chelating agent under investigation for the treatment of cancer and of Wilson's disease, a rare and potentially fatal disease in which the body cannot regulate copper. It is developed by Wilson Therapeutics and used in form of the salt bis-choline tetrathiomolybdate. Wilson's disease is an autosomal recessive genetic disorder that is manifested by serious hepatic, neurologic or psychiatric symptoms. The disease is fatal if left untreated. It is estimated that approximately 1 individual in every 30,000 worldwide has Wilson's disease, corresponding to approximately 15,000 individuals in the European Union and approximately 11,000 in the United States. Bis-choline tetrathiomolybdate has been evaluated in clinical trials in patients with various forms of cancer and has received orphan designation in the US and EU as a potential therapy against Wilson's disease. Pharmacology Mechanism of action Tiomolibdic acid selectively forms highly s ... [...More Info...] [...Related Items...] OR: [Wikipedia] [Google] [Baidu] |
